Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Commodities
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Real Time & Level II Data
Showcase Companies
DealRoom
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Ensysce Biosciences Inc
ENSC
Alternate Symbol(s):
ENSCW
Healthcare
Biotechnology
Ensysce Biosciences, Inc. is a clinical-stage biotech company. The Company is engaged in developing solutions for severe pain relief while reducing the potential for opioid misuse, abuse, and overdose. The Company is using its proprietary technology platforms to develop safer prescription drugs. The Company's development pipeline includes two new drug platforms: an abuse-resistant opioid...
prodrug technology - the Trypsin Activated Abuse Protection, (the TAAP platform), and an over-dose protection opioid prodrug technology - the Multi-Pill Abuse Resistant, (MPAR platform). The TAAP platform is designed to improve the care of patients with chronic pain while reducing the human and economic costs associated with prescription opioid drug abuse. The MPAR platform when combined with the Company’s TAAP prodrugs is designed not only to seek to prevent abuse of prescription drugs but also to reduce overdose occurrences.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (NDAQ:ENSC)
New Post
View:
Posts & Comments
Threaded Posts
Prev
1
2
3
Next
(0)
•••
PressRelease
X
Post by
PressRelease
on Jun 07, 2023 9:56am
New Press Release - Ensysce Biosciences Releases Updated Investor Presentation Available Via Investor Relations Website
SAN DIEGO, CA / ACCESSWIRE / June 7, 2023 / Ensysce Biosciences, Inc. (NASDAQ:ENSC), a clinical-stage company applying transformative chemistry to improve prescription drug safety, today announced an updated investor presentation has been posted to the Company's investor relations website. The...
read article.
(0)
•••
PressRelease
X
Post by
PressRelease
on Jun 06, 2023 8:05am
New Press Release - Ensysce Biosciences to Participate in Upcoming Industry Events
Chief Medical Officer, Dr. William Schmidt, to Present at the CPDD 85th Annual Scientific MeetingChief Commercial Officer, Geoff Birkett, to Present Opening Address at EPHMRA 2023 Annual ConferenceSAN DIEGO, CA / ACCESSWIRE / June 6, 2023 / Ensysce Biosciences, Inc. (NASDAQ:ENSC), a clinical...
read article.
Argentina Lithium Announces US$90 Million Investment by Stellantis
posted Sep 29, 2023 9:00am by
Argentina Lithium & Energy Corp.
-
|
Stellantis, one of the world's leading automakers has agreed to invest US$90 million in Argentina to acquire shares of ALE. The proceeds of the Transaction will be used to advance development of the Company's lithium projects held through its wholly owned subsidiary in Argentina. ...read more
(0)
•••
PressRelease
X
Post by
PressRelease
on May 15, 2023 4:30pm
New Press Release - Ensysce Biosciences Reports First Quarter 2023 Financial Results
Recently Completed Successful Ground-Breaking Study on Overdose Protection Recently Completed $7 Million Public OfferingSAN DIEGO, CA / ACCESSWIRE / May 15, 2023 /Ensysce Biosciences, Inc. ("Ensysce" or the "Company")(NASDAQ:ENSC), a clinical-stage company applying transformative chemistry to...
read article.
(0)
•••
PressRelease
X
Post by
PressRelease
on May 12, 2023 4:40pm
New Press Release - Ensysce Biosciences, Inc. Announces Closing of $7 Million Public Offering
SAN DIEGO, CA / ACCESSWIRE / May 12, 2023 / Ensysce Biosciences, Inc.(NASDAQ:ENSC) (the "Company"), a clinical-stage biotech company applying transformative chemistry to improve prescription drug safety to reduce abuse and overdose, announced today the closing of the previously announced public...
read article.
(82)
•••
Iseneschal
X
Post by
Iseneschal
on May 10, 2023 8:58am
ENSC.... I have to give kudos to ENSC
I found this Co played by the rules and they were transparent enough to be able to pick spots to enter and exit. Most Co's are the complete opposite Cheers and Good Luck to ENSC !
(0)
•••
PressRelease
X
Post by
PressRelease
on May 10, 2023 8:03am
New Press Release - Ensysce Biosciences, Inc. Announces Pricing of $7 Million Public Offering
SAN DIEGO, CA / ACCESSWIRE / May 10, 2023 / Ensysce Biosciences, Inc.(NASDAQ:ENSC) (the "Company"), a clinical-stage biotech company applying transformative chemistry to improve prescription drug safety to reduce abuse and overdose, announced today announced the pricing of a public offering of an...
read article.
(82)
•••
Iseneschal
X
Post by
Iseneschal
on May 09, 2023 12:57pm
ENSC....filed yesterday...Check it out!
https://www.sec.gov/ix?doc=/Archives/edgar/data/0001716947/000149315223015752
(82)
•••
Iseneschal
X
Post by
Iseneschal
on May 09, 2023 9:38am
ENSC..... Great way to start off the morning ; )
That's a big F'king Cha Ching Sold all into the strength...... I feel confident this will go even higher ...past $7..... Remember...they will want to raise money I bet this will be a double
...more
(82)
•••
Iseneschal
X
Post by
Iseneschal
on May 09, 2023 9:10am
ENSC.... Seems to me that this should go much higher
Based on past performance..... ENSC traded almost 4.5 million shares on 04/19/23 just on this NR: Ensysce CEO Dr. Lynn Kirkpatrick To Present Featured Case Study of MPAR Overdose Protection Platform
...more
(82)
•••
Iseneschal
X
Post by
Iseneschal
on May 09, 2023 8:45am
ENSC..Great morning Folks...NR and volume/ sh price increase
Cheers !! Ensysce Biosciences Announces Successful Completion of Ground-Breaking Study on Overdose Protection 2023-05-09 05:02 PT - News Release ~ Represents Major Milestone Towards Launch of
...more
(0)
•••
PressRelease
X
Post by
PressRelease
on May 09, 2023 8:01am
New Press Release - Ensysce Biosciences Announces Successful Completion of Ground-Breaking Study on Overdose Protection
~ Represents Major Milestone Towards Launch of PF614-MPAR ~~ PF614-MPAR on Track to be the First Drug to Protect Against Overdose ~SAN DIEGO, CA / ACCESSWIRE / May 9, 2023 / Ensysce Biosciences, Inc. (NASDAQ:ENSC), clinical-stage biotech company applying transformative chemistry to improve...
read article.
(82)
•••
Iseneschal
X
Post by
Iseneschal
on Apr 19, 2023 2:13pm
ENSC...... Is that a lil gap down ?
Vols have dried up....share price is getting whack.... Mr. M is licking his chops and laughing all the way to the bank. Now he's sayin..... Anymore weak hands?
(82)
•••
Iseneschal
X
Post by
Iseneschal
on Apr 19, 2023 1:58pm
ENSC.... 3rd 2 x's double bottom since 1 hr post open
And now for the next shoe to drop to sub $4 Wait for it ....Just keepin it real ; ) JMHO
(82)
•••
Iseneschal
X
Post by
Iseneschal
on Apr 19, 2023 12:32pm
ENSC..... It looks like The Maggots are playing a different
trading style these days. Just to screw everyone around and to not let John. Q Public know what they are doing. This deal is going to tank..... JMHO currently at $4.67
(82)
•••
Iseneschal
X
Post by
Iseneschal
on Apr 19, 2023 11:56am
ENSC..... By the way..... all the Frontloaders will be
re-loading sub $4.72 Cheers !
Prev
1
2
3
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Featured News Links
Energy Co. Announces Low Dilutive Development Capital Raise
Metallurgical Test Program at Los Cuyes Yielded Excellent Gold Recoveries
Eminent Gold has signed a purchase & sale agreement with Orogen Royalties for property in Nevada
Copper Exploration Company is on the Edge of a Big Discovery
Harness the Power: Elevate Your Understanding of Battery Metals & EVs - Free Insights Report Av alible